High Purity Mt2 CAS 121062-08-6 Raw Material Peptide Melanotan II Customized Peptide
TDS 81 Inquiries
121062-08-6
Pharmaceutical Grade
99%
Guangzhou
TOPI
10mg*10 vials/box
2026-12-31
peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionMelanotan (MT)-II, a synthetic melanocortin receptor agonist, is an injectable peptide hormone used to promote tanning.Certificates
-
TDS
Basic Info-
Product Name:
Mt-2
Other Name:melanotan-II;Melanotan II;MT-II;Melanotan (MT)-II;Melatonan;Melanotan II acetate salt;CHEMBL430239;(3S,6S,9R,12S,15S,23S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-3-yl)methyl)-15-((S)-2-acetamidohexanamido)-9-benzyl-6-(3-guanidinopropyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide;L-Lysinamide, N-acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-, cyclic (2-7)-peptide
CAS No.:121062-08-6
Molecular Formula:C50H69N15O9
InChIKeys:JDKLPDJLXHXHNV-MFVUMRCOSA-N
Molecular Weight:1024.18
Exact Mass:1023.540283
EC Number:1308068-626-2
UNII:UPF5CJ93X7
DSSTox ID:DTXSID90153135
Categories:
Characteristics-
PSA:
382.26000
XLogP3:-1.27
Appearance:white solid
Density:1.4±0.1 g/cm3
Refractive Index:1.683
Water Solubility:H2O: 5 mg/mL, soluble
Storage Conditions:−20°C
Research-
Class:
Synthetic cyclic heptapeptide / non-selective melanocortin receptor agonist
Status:Research compound — NOT FDA approved. FDA issued warning letters. WADA banned substance.
Mechanism:A synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) analog of α-MSH. Melanotan II is a high-affinity non-selective agonist at MC1R, MC3R, MC4R, and MC5R. MC1R activation induces melanogenesis (skin darkening/tanning); MC4R activation affects sexual function, appetite suppression, and energy homeostasis. Carries significant safety risks including nausea, hypertension, and priapism.
EC50 (Human Mc1r Ki):1.2 nM
EC50 (Human Mc5r Ki):1.0 nM
EC50 (Human Mc3r Ki):1.1 nM
EC50 (Human Mc4r Ki):2.1 nM
Source:Wikberg JES, et al. Pharmacol Res. 2000;42(5):393–420. PubChem CID 92432.DOI
Clinical Development:
References-
ChEMBL:
CHEMBL363210
PubChem:Literature:FDA Warning Letters: Melanotan II (unapproved drug); WADA Prohibited List: Melanotan II (S2 hormone modulator)
Disclaimer:Melanotan II is NOT FDA-approved. The FDA has issued multiple warning letters to companies illegally selling Melanotan II as an unapproved new drug. It is also listed on the WADA Prohibited List as a banned substance in sport. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax
-
Location:
Units 1503-14, 15th Floor, New HNA Building, No. 7 Guoxing Avenue, Lantian Subdistrict, Meilan District, Haikou City, Hainan Province
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
101-200
-
Year of Establishment:
2025
-
-
Inquiry History81 Inquiries
Country Product Purchase Quantity Date Posted 
United Kingdom
Melanotan II 121062-08-6 98% white powder
30 MT Nov 21, 2023 
United States
Purity MT2 CAS 121062-08-6 Melanotan II peptide MT2
2 MT Oct 22, 2025 
Philippines
QSC Supply 99% Purity 121062-08-6 Melanotan II peptide MT2
4 MT Sep 16, 2023 
Ireland
10mg 1g CAS 121062-08-6 MT-2/ MT-1/ Melanotan II Raw powder
5 MT Nov 12, 2023 
Malaysia
10mg 1g CAS 121062-08-6 MT-2/ MT-1/ Melanotan II Raw powder
10 KG Nov 19, 2023
United Kingdom
Mt-2
20 MT Jul 5, 2026 
China
high quality MT2 Peptide purity >99% factory selling in stock Lyophilized powder
1 MT Jun 29, 2026
United Kingdom
mt-2
10 MG Jun 23, 2026
United Kingdom
Mt2
1 KG Jun 22, 2026 
Australia
Melanotan 2
1 MT Jun 17, 2026
United States
Melanotan 2
200 MG May 29, 2026
United Kingdom
melanotan 2
1 KG Apr 6, 2026 
Sweden
melanotan 2
50 MT Feb 18, 2026
United States
Melanotan 2
100 MG Jan 27, 2026
United Kingdom
MTII
2 G Nov 21, 2025
Ireland
Melanotan 2
1 KG Nov 10, 2025 
Poland
melanotan
1 Oct 2, 2025
United Kingdom
Melanotan 2
1 MT Aug 31, 2025
United Kingdom
Melanotan 2
1 KG Jun 10, 2025
United States
Melanotan 2 acetate
10 MG May 23, 2025 Post an enquiry for this product
